Compare Stocks

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATE Antibe Therapeutics	C$0.30	C$0.51	C$0.15 ▼ C$1.23	C$15.54M	0.12	135,475 shs	N/A
FRX Forest Road Acquisition		$10.30	$9.72 ▼ $18.20	$450M	N/A	2.07 million shs	40,482 shs
IMV IMV		$0.66	$0.48 ▼ $12.70	$9.63M	0.95	233,607 shs	44,800 shs
RPHM Reneo Pharmaceuticals	$1.64 -2.3%	$1.66	$0.98 ▼ $10.98	$54.83M	0.24	272,492 shs	78,923 shs
SNG Silver Range Resources	C$0.10 +11.8%	C$0.08	C$0.06 ▼ C$0.15	C$9.02M	-0.03	30,953 shs	1,500 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATE Antibe Therapeutics	0.00%	0.00%	-31.40%	-67.58%	-45.37%
FRX Forest Road Acquisition	0.00%	0.00%	0.00%	0.00%	0.00%
IMV IMV	0.00%	0.00%	0.00%	0.00%	+1.54%
RPHM Reneo Pharmaceuticals	+0.30%	-5.08%	+0.60%	-0.59%	-81.64%
SNG Silver Range Resources	0.00%	-5.00%	+35.71%	+35.71%	-29.63%

World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATE Antibe Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FRX Forest Road Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IMV IMV	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RPHM Reneo Pharmaceuticals	1.7253 of 5 stars	2.9	0.0	0.0	0.0	3.2	2.5	1.3
SNG Silver Range Resources	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATE Antibe Therapeutics	2.00	Hold	N/A	N/A
FRX Forest Road Acquisition	N/A	N/A	N/A	N/A
IMV IMV	2.00	Hold	N/A	N/A
RPHM Reneo Pharmaceuticals	1.88	Reduce	$18.14	1,005.54% Upside
SNG Silver Range Resources	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest RPHM, FRX, SNG, IMV, and ATE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/4/2024	ATE Antibe Therapeutics	Brookline Capital Management Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATE Antibe Therapeutics	C$9.71M	1.60	C$0.48 per share	0.61	C$0.49 per share	0.60
FRX Forest Road Acquisition	N/A	N/A	N/A	N/A	$0.56 per share	N/A
IMV IMV	$330K	0.00	N/A	N/A	($0.69) per share	0.00
RPHM Reneo Pharmaceuticals	N/A	N/A	N/A	N/A	$2.66 per share	N/A
SNG Silver Range Resources	N/A	N/A	C$0.01 per share	16.25	C$0.11 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATE Antibe Therapeutics	-C$18.24M	-C$0.35	N/A	∞	N/A	N/A	-52.72%	-19.13%	7/4/2024 (Estimated)
FRX Forest Road Acquisition	-$7.92M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
IMV IMV	-$37.99M	-$4.59	N/A	N/A	N/A	-11,547.42%	-12,695.41%	-104.84%	N/A
RPHM Reneo Pharmaceuticals	-$77.39M	-$2.52	N/A	N/A	N/A	N/A	-73.14%	-63.85%	5/9/2024 (Estimated)
SNG Silver Range Resources	-C$1.69M	-C$0.02	N/A	∞	N/A	N/A	-16.23%	-9.12%	5/2/2024 (Estimated)

Latest RPHM, FRX, SNG, IMV, and ATE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/28/2024	Q4 2023	RPHM Reneo Pharmaceuticals	-$0.55	-$0.70	-$0.15	-$0.70	N/A	N/A
2/14/2024	Q3 2024	ATE Antibe Therapeutics	-C$0.12	-C$0.08	+C$0.04	-C$0.08	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATE Antibe Therapeutics	C$0.05	16.95%	N/A	N/A	N/A
FRX Forest Road Acquisition	N/A	N/A	N/A	N/A	N/A
IMV IMV	N/A	N/A	N/A	N/A	N/A
RPHM Reneo Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
SNG Silver Range Resources	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATE Antibe Therapeutics	0.29	10.06	9.58
FRX Forest Road Acquisition	N/A	0.37	0.37
IMV IMV	N/A	2.93	2.93
RPHM Reneo Pharmaceuticals	N/A	5.87	5.87
SNG Silver Range Resources	0.07	5.82	7.93

Ownership

Institutional Ownership

Company	Institutional Ownership
ATE Antibe Therapeutics	N/A
FRX Forest Road Acquisition	N/A
IMV IMV	15.37%
RPHM Reneo Pharmaceuticals	90.98%
SNG Silver Range Resources	N/A

Insider Ownership

Company	Insider Ownership
ATE Antibe Therapeutics	7.94%
FRX Forest Road Acquisition	N/A
IMV IMV	0.33%
RPHM Reneo Pharmaceuticals	17.90%
SNG Silver Range Resources	38.33%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ATE Antibe Therapeutics	11	52.67 million	N/A	Not Optionable
FRX Forest Road Acquisition	N/A	37.50 million	N/A	Not Optionable
IMV IMV	97	11.71 million	11.67 million	Optionable
RPHM Reneo Pharmaceuticals	8	33.42 million	27.44 million	Optionable
SNG Silver Range Resources	N/A	94.97 million	N/A	Not Optionable

RPHM, FRX, SNG, IMV, and ATE Headlines

Source	Headline
	Silver Range Resources Ltd. to Present at Metals & Mining Virtual Investor Conference May 2nd finance.yahoo.com - April 24 at 5:37 PM
	State Police Asking for Public’s Help Locating Suspect Vehicles in Fatal Pedestrian Hit-and-Run Crash townsquaredelaware.com - April 23 at 4:34 PM
	Gorgeous Anushka Sen Age, Height, Bio, Net Worth, Family, and More in 20240 technosports.co.in - April 9 at 10:25 AM
	Endicott Business Owners Brace for Big Washington Avenue Project wnbf.com - April 4 at 6:28 PM
	Silver Lake to Take Endeavor Private tmcnet.com - April 2 at 3:22 PM
	Outdoors North: No lack of beautiful landscapes to visit miningjournal.net - March 29 at 4:43 PM
	Burlington Free Press msn.com - March 28 at 12:49 PM
	How Quinta Brunson Hacked the Sitcom newyorker.com - March 18 at 9:43 AM
	Two Veteran Hikers Launch Seniq, an Outdoor Wear Line Catering to Women msn.com - March 14 at 7:20 PM
	Oct. 7: Rape as an instrument of genocide clevelandjewishnews.com - March 13 at 3:00 PM
	Review: Ariana Grande isn’t perfect, and neither is ‘eternal sunshine’ nyunews.com - March 13 at 9:59 AM
	Three Wyoming Authors Awarded Western Writing's Highest Honor cowboystatedaily.com - March 13 at 9:59 AM
	Skyfire, the Canberra Comedy Festival, and the Balloon Spectacular: 50+ things to do this week hercanberra.com.au - March 11 at 8:29 PM
	What’s happening around New Mexico February 23-29 msn.com - February 23 at 1:38 PM
	Game-changer for NJ beauty services: These are salon suites in New Jersey nj1015.com - February 21 at 4:33 PM
	THIS UNIVERSITY OF FLORIDA PROGRAM OFFERS INSIGHTS INTO SUSTAINABLE LANDSCAPING keysweekly.com - February 21 at 4:33 PM
	Texas tough: Defense shines when offense struggles in virtual must-win over Kansas State msn.com - February 20 at 7:40 AM
	UMG Nashville Launches Silver Wings Records, Signs Hueston yahoo.com - February 15 at 6:02 PM
	Dr. Jeremy Silver: Heart health risk factors to be aware of wgnradio.com - February 4 at 2:52 PM
	Multiplayer Strategy Game “RoboHero” Featuring Seamless Integration of Tokens and NFTs to Launch on WEMIX PLAY markets.businessinsider.com - February 4 at 9:52 AM
	Local Author's Book Available at Carson Tahoe Medical Center gift shop carsonnow.org - February 4 at 9:52 AM
	Carson High School debate team shines at home tournament carsonnow.org - January 31 at 2:37 PM
	23 Famous People With Amazing Hidden Talents msn.com - January 31 at 2:37 PM
	Today's events for Feb. 1 postandcourier.com - January 31 at 2:37 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Antibe Therapeutics

TSE:ATE

Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's pipeline includes therapies that seek to overcome the gastrointestinal (GI) ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead compound is Otenaproxesul, an NSAID that releases hydrogen sulfide for treating post-operative pain, migraine, acute musculoskeletal pain, dysmenorrhea, gout, and dental pain. In addition, its products comprise ATB-352, which is in preclinical stage for acute pain. The company was incorporated in 2009 and is headquartered in Toronto, Canada.

Forest Road Acquisition

NYSE:FRX

Forest Road Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology, media, and telecommunications space. The company was founded in 2020 and is based in New York, New York.

IMV

NASDAQ:IMV

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.

Reneo Pharmaceuticals

NASDAQ:RPHM

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company's lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.

Silver Range Resources

CVE:SNG

Silver Range Resources Ltd., a junior resource exploration company, engages in the acquisition, exploration, and evaluation of precious metal resources in Canada. The company explores for gold, silver, zinc, lead, and copper deposits. Its property portfolio comprises mineral properties located in Nevada, the Northwest Territories, Nunavut, and the Yukon Territory. Silver Range Resources Ltd. was incorporated in 2010 and is headquartered in Vancouver, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial